Investment firms Sofinnova Partners successfully closes its latest flagship fund, Sofinnova Capital XI, with €650 million to back a new generation of pioneering biopharmaceutical and medical technology companies addressing urgent unmet clinical needs Medicxi successfully closes its sixth fund, Medicxi V, with €500 million dedicated to building and backing innovative biotechnology companies with clear product […]
People in Europe and the US rarely pay for prescription drugs out of their own pockets. In Europe, their national health services almost always pick up the tab – even if some people have to contribute by way of a prescription charge. In the US, the health insurer normally foots the bill. But things have […]
Internationally recognized clinical strategist with proven track record in translating innovation into clinical impact joins Domain to advance its GPCR-targeting pipeline Appointment comes at a pivotal moment, following the initiation of Phase I/II development of DT-7012, a Treg-depleting anti-CCR8 antibody candidate Strasbourg, France – Montreal, Canada – Boston, United States, November 13, 2025: Domain Therapeutics […]
Presented by Optimum Strategic Communications and Catalyst Advisors, this guide is your key to Europe’s biggest week in life sciences. Join global investors, executives, and innovators for a packed schedule of conferences, panels, and networking events. Plan ahead, connect smart, and make every moment count!
Karen Baxter, former VP & GM at Dexcom with deep expertise in diabetes device commercialization across Europe, joins as SVP Sales, Europe Jay Little, leader from Medtronic Diabetes, appointed VP Strategy & Business Development Team expansion will drive growth strategy, market development, and partnerships for scalable expansion to accelerate Kaleido’s growth across European markets Utrecht, […]
